Beta-Lactam Antibiotic Resistance among Enterobacter spp. Isolated from Infection in Animals
暂无分享,去创建一个
[1] J. Weese. Investigation of Enterobacter cloacae infections at a small animal veterinary teaching hospital. , 2008, Veterinary microbiology.
[2] P. Graham,et al. Epidemiology of Enterococci in a Neonatal Intensive Care Unit , 2008, Infection Control & Hospital Epidemiology.
[3] A. L. Darini,et al. Clonal Transmission of ESBL-Producing Klebsiella spp. at a University Hospital in Brazil , 2008, Current Microbiology.
[4] D. Church,et al. Community-Wide Outbreaks of Clonally Related CTX-M-14 β-Lactamase-Producing Escherichia coli Strains in the Calgary Health Region , 2005, Journal of Clinical Microbiology.
[5] Y. Carmeli,et al. Extended-Spectrum Beta-Lactamases among Enterobacter Isolates Obtained in Tel Aviv, Israel , 2005, Antimicrobial Agents and Chemotherapy.
[6] R. Bonnet. Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes , 2004, Antimicrobial Agents and Chemotherapy.
[7] M. M. Rodríguez,et al. Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals. , 2003, Antimicrobial agents and chemotherapy.
[8] D. Hocquet,et al. Molecular epidemiology of Enterobacteriaceae producing extended-spectrum β-lactamase in a French university-affiliated hospital , 2003 .
[9] N. Hanson. AmpC β-lactamases: what do we need to know for the future? , 2003 .
[10] R. Bonnet,et al. CTX-M-1, CTX-M-3, and CTX-M-14 β-Lactamases from Enterobacteriaceae Isolated in France , 2002, Antimicrobial Agents and Chemotherapy.
[11] S. Cosgrove,et al. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. , 2002, Archives of internal medicine.
[12] D. Christmann,et al. Bacteremia and endocarditis caused by a Gordonia species in a patient with a central venous catheter. , 2000, Emerging infectious diseases.
[13] A. Tsakris,et al. Detection of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacter cloacae andEnterobacter aerogenes , 2000, Journal of Clinical Microbiology.
[14] J. Butzler,et al. Molecular Epidemiological Study of NosocomialEnterobacter aerogenes Isolates in a Belgian Hospital , 1998, Journal of Clinical Microbiology.
[15] L. Bret,et al. Chromosomally Encoded AmpC-Type β-Lactamase in a Clinical Isolate of Proteus mirabilis , 1998, Antimicrobial Agents and Chemotherapy.
[16] P. Coudron,et al. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find , 1997, Journal of clinical microbiology.
[17] C. Sanders,et al. Enterobacter spp.: pathogens poised to flourish at the turn of the century , 1997, Clinical microbiology reviews.
[18] C. Quentin,et al. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit , 1996, Journal of clinical microbiology.
[19] A. Péchinot,et al. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae , 1996, Journal of clinical microbiology.
[20] G. Papanicolaou,et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility , 1990, Antimicrobial Agents and Chemotherapy.
[21] Jose Mario F de Oliveira,et al. Hospital-acquired infections due to gram-negative bacteria. , 2010, The New England journal of medicine.
[22] N. Hanson. AmpC beta-lactamases: what do we need to know for the future? , 2003, The Journal of antimicrobial chemotherapy.
[23] A. Tsakris,et al. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. , 2000, Journal of clinical microbiology.